Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2026 ,inter alia, to consider and approve Board Meeting intimation for ....
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Corona Remedies Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, February 2, 2026. The key agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the third quarter and nine months ended December 31, 2025. The company has also confirmed that the trading window for dealing in its securities remains closed until Wednesday, February 4, 2026, in line with insider trading regulations.
This is a routine pre-results announcement and does not carry any direct fundamental impact on the stock. Investors should watch for the actual Q3FY26 results on or after February 2, 2026, as any meaningful revenue or profit deviation could move the stock. The closed trading window signals that insiders are restricted from trading until results are published.